These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26777256)

  • 1. Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.
    Wallace S; Guo DC; Regalado E; Mellor-Crummey L; Bamshad M; Nickerson DA; Dauser R; Hanchard N; Marom R; Martin E; Berka V; Sharina I; Ganesan V; Saunders D; Morris SA; Milewicz DM
    Clin Genet; 2016 Oct; 90(4):351-60. PubMed ID: 26777256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy.
    Guey S; Hervé D; Kossorotoff M; Ha G; Aloui C; Bergametti F; Arnould M; Guenou H; Hadjadj J; Dubois Teklali F; Riant F; Balligand JL; Uzan G; Villoutreix BO; Tournier-Lasserve E
    Hum Genomics; 2023 Mar; 17(1):24. PubMed ID: 36941667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.
    Hervé D; Philippi A; Belbouab R; Zerah M; Chabrier S; Collardeau-Frachon S; Bergametti F; Essongue A; Berrou E; Krivosic V; Sainte-Rose C; Houdart E; Adam F; Billiemaz K; Lebret M; Roman S; Passemard S; Boulday G; Delaforge A; Guey S; Dray X; Chabriat H; Brouckaert P; Bryckaert M; Tournier-Lasserve E
    Am J Hum Genet; 2014 Mar; 94(3):385-94. PubMed ID: 24581742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moyamoya Disease 6 with Achalasia Due to GUCY1A3 Mutation in a Child.
    Ramesh V; Sankar J
    Neurol India; 2020; 68(5):1253-1254. PubMed ID: 33109895
    [No Abstract]   [Full Text] [Related]  

  • 5. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Characterization of the
    Kessler T; Wobst J; Wolf B; Eckhold J; Vilne B; Hollstein R; von Ameln S; Dang TA; Sager HB; Moritz Rumpf P; Aherrahrou R; Kastrati A; Björkegren JLM; Erdmann J; Lusis AJ; Civelek M; Kaiser FJ; Schunkert H
    Circulation; 2017 Aug; 136(5):476-489. PubMed ID: 28487391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling.
    Emdin CA; Khera AV; Klarin D; Natarajan P; Zekavat SM; Nomura A; Haas M; Aragam K; Ardissino D; Wilson JG; Schunkert H; McPherson R; Watkins H; Elosua R; Bown MJ; Samani NJ; Baber U; Erdmann J; Gormley P; Palotie A; Stitziel NO; Gupta N; Danesh J; Saleheen D; Gabriel S; Kathiresan S
    Circulation; 2018 Jan; 137(3):222-232. PubMed ID: 28982690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DIAPH1 Variants in Non-East Asian Patients With Sporadic Moyamoya Disease.
    Kundishora AJ; Peters ST; Pinard A; Duran D; Panchagnula S; Barak T; Miyagishima DF; Dong W; Smith H; Ocken J; Dunbar A; Nelson-Williams C; Haider S; Walker RL; Li B; Zhao H; Thumkeo D; Marlier A; Duy PQ; Diab NS; Reeves BC; Robert SM; Sujijantarat N; Stratman AN; Chen YH; Zhao S; Roszko I; Lu Q; Zhang B; Mane S; Castaldi C; López-Giráldez F; Knight JR; Bamshad MJ; Nickerson DA; Geschwind DH; Chen SL; Storm PB; Diluna ML; Matouk CC; Orbach DB; Alper SL; Smith ER; Lifton RP; Gunel M; Milewicz DM; Jin SC; Kahle KT
    JAMA Neurol; 2021 Aug; 78(8):993-1003. PubMed ID: 34125151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher susceptibility to heme oxidation and lower protein stability of the rare α
    Sharina I; Lezgyieva K; Krutsenko Y; Martin E
    Biochem Pharmacol; 2021 Apr; 186():114459. PubMed ID: 33571505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants.
    Wobst J; von Ameln S; Wolf B; Wierer M; Dang TA; Sager HB; Tennstedt S; Hengstenberg C; Koesling D; Friebe A; Braun SL; Erdmann J; Schunkert H; Kessler T
    Basic Res Cardiol; 2016 Jul; 111(4):51. PubMed ID: 27342234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1.
    Santoro C; Giugliano T; Kraemer M; Torella A; Schwitalla JC; Cirillo M; Melis D; Berlit P; Nigro V; Perrotta S; Piluso G
    PLoS One; 2018; 13(7):e0200446. PubMed ID: 30001348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation genotypes of RNF213 gene from moyamoya patients in Taiwan.
    Lee MJ; Chen YF; Fan PC; Wang KC; Wang K; Wang J; Kuo MF
    J Neurol Sci; 2015; 353(1-2):161-5. PubMed ID: 25956231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between GUCY1A3 genetic polymorphisms and large artery atherosclerotic stroke risk in Chinese Han population: a case-control study.
    Li JL; Liu LY; Jiang DD; Jiang YY; Zhou GQ; Mo DC; Luo M
    Lipids Health Dis; 2019 Dec; 18(1):233. PubMed ID: 31883534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine nitric oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble guanylyl cyclase/cyclic-guanosine monophosphate and Wnt/β-catenin inhibition.
    De Pauw A; Massion P; Sekkali B; Andre E; Dubroca C; Kmecova J; Bouzin C; Friart A; Sibille C; Gilon P; De Mulder D; Esfahani H; Strapart A; Martherus R; Payen V; Sonveaux P; Brouckaert P; Janssens S; Balligand JL
    Cardiovasc Res; 2016 Oct; 112(1):478-90. PubMed ID: 27520736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and significance of rare RNF213 variants in patients with adult moyamoya disease.
    Jang MA; Chung JW; Yeon JY; Kim JS; Hong SC; Bang OY; Ki CS
    PLoS One; 2017; 12(6):e0179689. PubMed ID: 28617845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation at the coronary artery disease risk locus GUCY1A3 modifies cardiovascular disease prevention effects of aspirin.
    Hall KT; Kessler T; Buring JE; Passow D; Sesso HD; Zee RYL; Ridker PM; Chasman DI; Schunkert H
    Eur Heart J; 2019 Nov; 40(41):3385-3392. PubMed ID: 31228190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention.
    Kessler T; Wolf B; Eriksson N; Kofink D; Mahmoodi BK; Rai H; Tragante V; Åkerblom A; Becker RC; Bernlochner I; Bopp R; James S; Katus HA; Mayer K; Munz M; Nordio F; O'Donoghue ML; Sager HB; Sibbing D; Solakov L; Storey RF; Wobst J; Asselbergs FW; Byrne RA; Erdmann J; Koenig W; Laugwitz KL; Ten Berg JM; Wallentin L; Kastrati A; Schunkert H
    Cardiovasc Res; 2019 Aug; 115(10):1512-1518. PubMed ID: 30768153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
    Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
    World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proatherosclerotic Effect of the α1-Subunit of Soluble Guanylyl Cyclase by Promoting Smooth Muscle Phenotypic Switching.
    Segura-Puimedon M; Mergia E; Al-Hasani J; Aherrahrou R; Stoelting S; Kremer F; Freyer J; Koesling D; Erdmann J; Schunkert H; de Wit C; Aherrahrou Z
    Am J Pathol; 2016 Aug; 186(8):2220-2231. PubMed ID: 27315776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.